61. Molecular Targets for Treatment of HCV and Antiviral Resistance
Session: Symposium: Treatment of Hepatitis C
Thursday, October 27, 2016: 9:00 AM
Room: 278-282
David Wyles, MD, University of California at San Diego, La Jolla, CA


Disclosures:

D. Wyles, AbbVie: Consultant and Research Contractor , Consulting fee and Research support
Bristol Myers Squibb: Consultant and Research Contractor , Consulting fee and Research support
Gilead: Consultant and Research Contractor , Consulting fee and Research support
Merck: Consultant and Research Contractor , Consulting fee and Research support

See more of: Treatment of Hepatitis C
See more of: Symposium
<< Previous Presentation | Next Presentation >>

Findings in the abstracts are embargoed until 12:01 a.m. CDT, Wednesday Oct. 26th with the exception of research findings presented at the IDWeek press conferences.